Sofinnova Investments as of Sept. 30, 2021
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 70 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera Comm (NTRA) | 20.5 | $346M | 3.1M | 111.44 | |
| Karuna Therapeutics Comm | 14.1 | $239M | 2.0M | 122.33 | |
| Ascendis Pharma A/S Adr (ASND) | 4.7 | $80M | 500k | 159.39 | |
| Aerovate Therapeutics Comm (AVTE) | 4.7 | $79M | 3.8M | 20.98 | |
| AstraZeneca Adr (AZN) | 4.0 | $68M | 1.1M | 60.06 | |
| Y-mAbs Therapeutics Comm | 3.7 | $63M | 2.2M | 28.54 | |
| Vera Therapeutics Cl A (VERA) | 3.0 | $51M | 2.9M | 17.35 | |
| Merck & Co Call Call Option | 2.7 | $45M | 600k | 75.11 | |
| United Therapeutics Corp Comm (UTHR) | 2.4 | $41M | 222k | 184.58 | |
| Bolt Biotherapeutics Comm | 2.1 | $35M | 2.8M | 12.65 | |
| Align Technology Comm (ALGN) | 1.9 | $31M | 47k | 665.43 | |
| Abbvie Comm (ABBV) | 1.7 | $29M | 273k | 107.87 | |
| Galera Therapeutics Comm (GRTX) | 1.5 | $25M | 3.1M | 8.10 | |
| Heron Therapeutics Comm (HRTX) | 1.5 | $25M | 2.3M | 10.69 | |
| Bristol-Myers Squibb Call Call Option | 1.4 | $24M | 400k | 59.17 | |
| Inozyme Pharma Comm (INZY) | 1.4 | $24M | 2.0M | 11.59 | |
| Dexcom Comm (DXCM) | 1.2 | $20M | 37k | 546.85 | |
| Blueprint Medicines Corp Comm (BPMC) | 1.1 | $19M | 182k | 102.81 | |
| Regeneron Pharmaceuticals Put Put Option | 1.1 | $18M | 30k | 605.17 | |
| Nextcure Comm (NXTC) | 1.1 | $18M | 2.7M | 6.74 | |
| Akouos Comm | 1.0 | $18M | 1.5M | 11.61 | |
| United Therapeutics Corp Put Put Option | 1.0 | $17M | 95k | 184.58 | |
| Horizon Therapeutics Pub L SHS | 1.0 | $17M | 158k | 109.54 | |
| Reata Pharmaceuticals Comm | 0.9 | $16M | 158k | 100.61 | |
| Cytokinetics Comm (CYTK) | 0.9 | $15M | 427k | 35.74 | |
| ObsEva SA Comm | 0.9 | $15M | 4.7M | 3.11 | |
| Zoetis Cl A (ZTS) | 0.9 | $15M | 76k | 194.14 | |
| Insmed Comm (INSM) | 0.9 | $15M | 535k | 27.54 | |
| Sarepta Therapeutics Comm (SRPT) | 0.9 | $15M | 157k | 92.48 | |
| Nucana Adr | 0.9 | $14M | 5.6M | 2.58 | |
| Checkmate Pharmaceuticals Comm | 0.8 | $14M | 3.6M | 3.97 | |
| Kura Oncology Comm (KURA) | 0.8 | $14M | 755k | 18.73 | |
| Agenus Comm | 0.7 | $12M | 2.3M | 5.25 | |
| Zymeworks Comm | 0.7 | $12M | 411k | 29.04 | |
| Travere Therapeutics Comm (TVTX) | 0.6 | $11M | 437k | 24.25 | |
| Exelixis Comm (EXEL) | 0.6 | $10M | 488k | 21.14 | |
| Mirati Therapeutics Comm | 0.6 | $10M | 57k | 176.91 | |
| Biogen Comm (BIIB) | 0.6 | $9.4M | 33k | 282.99 | |
| Kadmon Holdings Comm | 0.5 | $9.1M | 1.0M | 8.71 | |
| ChemoCentryx Comm | 0.5 | $8.9M | 518k | 17.10 | |
| ChemoCentryx Put Put Option | 0.5 | $8.6M | 506k | 17.10 | |
| PTC Therapeutics Comm (PTCT) | 0.5 | $8.6M | 230k | 37.21 | |
| Intra-Cellular Therapies Comm (ITCI) | 0.5 | $8.5M | 227k | 37.28 | |
| ALX Oncology Holdings Comm (ALXO) | 0.5 | $7.9M | 107k | 73.86 | |
| Syndax Pharmaceuticals Comm (SNDX) | 0.5 | $7.9M | 414k | 19.11 | |
| Celldex Therapeutics Comm (CLDX) | 0.4 | $7.4M | 137k | 53.99 | |
| Acceleron Pharma Comm | 0.4 | $6.8M | 40k | 172.09 | |
| Immatics Comm (IMTX) | 0.4 | $6.2M | 478k | 13.00 | |
| Nucana Ordinary Shares | 0.4 | $6.2M | 2.4M | 2.58 | |
| CTI BioPharma Corp Comm | 0.4 | $6.1M | 2.1M | 2.95 | |
| Iveric Bio Comm | 0.3 | $5.8M | 357k | 16.24 | |
| Amarin Corp Adr | 0.3 | $5.5M | 1.1M | 5.10 | |
| Regenxbio Comm (RGNX) | 0.3 | $5.3M | 128k | 41.92 | |
| Protagonist Therapeutics Call Call Option | 0.3 | $5.3M | 300k | 17.72 | |
| Protagonist Therapeutics Comm (PTGX) | 0.3 | $5.3M | 298k | 17.72 | |
| Guardant Health Comm (GH) | 0.3 | $5.0M | 40k | 125.00 | |
| Jounce Therapeutics Comm | 0.3 | $4.7M | 637k | 7.43 | |
| Sierra Oncology Comm | 0.3 | $4.5M | 207k | 21.92 | |
| Cyteir Therapeutics Comm | 0.3 | $4.3M | 246k | 17.55 | |
| Iveric Bio Put Put Option | 0.2 | $4.1M | 255k | 16.24 | |
| Novocure Call Call Option | 0.2 | $3.5M | 30k | 116.17 | |
| Intercept Pharmaceuticals In Call Call Option | 0.2 | $2.8M | 190k | 14.85 | |
| Uniqure NV Comm (QURE) | 0.1 | $2.5M | 79k | 32.02 | |
| PDS Biotechnology Corporation Comm (PDSB) | 0.1 | $2.1M | 143k | 14.90 | |
| Aligos Therapeutics Comm | 0.1 | $1.9M | 124k | 15.51 | |
| Marinus Pharmaceuticals Comm | 0.1 | $1.9M | 167k | 11.38 | |
| Synlogic Comm | 0.1 | $1.8M | 575k | 3.05 | |
| Fulcrum Therapeutics Comm (FULC) | 0.1 | $1.4M | 51k | 28.21 | |
| Fusion Pharmaceuticals Comm | 0.0 | $618k | 78k | 7.92 | |
| Insulet Corp Comm (PODD) | 0.0 | $303k | 1.1k | 284.24 |